Lecture 13 Flashcards
A genomic island that increases the “fitness” of a microorganism is called a(n) ____.
A) plasmid gene
B) pathogenicity island
C) phage gene
D) secretion system
B) pathogenicity island
____ move whole blocks of DNA from one organism to another.
Horizontal gene transfers
If the genomic island increases the “fitness” of a microorganism during interaction with a host, it is called a ____.
pathogenicity island
Which of the following is NOT a feature of a pathogenicity island?
A) They can be acquired through horizontal gene transmission.
B) They don’t confer fitness to the pathogen.
C) They are flanked by plasmid or phage sequences.
D) The ratio of GC/AT is different in the islands vs. the genome.
B) They don’t confer fitness to the pathogen.
Pathogenecity islands are acquired through ____.
horizontal gene transmission
Because the pathogenecity island is different, the ___ sequence is different from the genome.
GC/AT
The pathogenicity island is flanked by ____.
plasmid or phage sequences
All of the following are used for microbial attachment EXCEPT _____.
A) capsids
B) pili
C) fimbriae
D) ribosomes
D) ribosomes
Examples of microbial attachments
Capsids, envelopes, pili, and fimbriae
Exotoxins target all of the following EXCEPT _____.
A) vesicular trafficking
B) cytoskeleton alteration
C) protein synthesis
D) DNA synthesis
D) DNA synthesis
8 categories of microbial exotoxins
plasma membrane disruption,
cytoskeleton alterations
protein synthesis disruption
cell cycle disruption
signal transduction disruption
cell-cell adhesion disruption
vesicular trafficking
exocytosis
All of the following are methods intracellular pathogens can use to survive inside a host cell EXCEPT _____.
A) create a capsule.
B) escape the phagosome.
C) survive in the phagolysosome.
D) prevent phagosome-lysosome fusion
A) create a capsule.
Once inside the phagosome, intracellular pathogens have three options to avoid being killed by the phagolysosome:
survive in a phagolysosome
prevent phagosome-lysosome fusion
escape the phagosome
Protozoan antigenic variation causes the host’s immune system to continually make______.
A) macrophages
B) T-cells
C) NK cells
D) antibodies
D) antibodies
Switching to a new VSG (antigenic variation) allows the pathogen to avoid the ____ and is allowed to produce more ____.
antibody response; organisms
Small genetic changes to a virus that result in viruses with similar antigenic properties is called _____.
A) antigenic drift
B) antigenic shift
C) toxin production
D) antigenic variation
A) antigenic drift
All of the following are methods protozoans use to avoid the host immune response EXCEPT ____.
A) antigenic masking
B) toxin production
C) antigenic variation
D) immunosuppression
B) toxin production
Protozoans lack potent ___.
toxins
Protozoan immune-avoidance strategies include (4):
antigenic masking
antigenic variation
intracellular location
immunosuppression
Genomic island
a horizontally acquired region of the bacterial chromosome that has an altered GC content and segments of phages or plasmid DNA that mark it as different from the rest of the genome
Pathogenicity island
a genomic island that contains virulence factors that increase the fitness of the organism in the host
Capsule
coat bacterial cell walls and can prevent phagocytes from binding
Cell-surface proteins are components of the cell wall that ____.
prevent detection
Quorum sensing
used to communicate with other pathogens about population size
Antigenic variation
100 known serotypes of rhinovirus; each virus has a unique capsid protein. Antibodies to one capsid protein are not effective on another
Antigenic shift
Two strains of influenza virus infect the same cell and the genomes get mixed. This makes a dramatically different virus
Antigenic drift
Random mutations can occur within the cell that a virus infects creating small changes in virus proteins
Antigenic Masking
Some protozoans coat themselves in host antigens to avoid detection by the immune system
Antigenic Variation
Just like viruses and bacteria, some protozoans can alter their surface antigens to prevent antibody binding